252 related articles for article (PubMed ID: 15022184)
1. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
[TBL] [Abstract][Full Text] [Related]
2. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
[TBL] [Abstract][Full Text] [Related]
4. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
5. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
Truong D; Brodsky M; Lew M; Brashear A; Jankovic J; Molho E; Orlova O; Timerbaeva S;
Parkinsonism Relat Disord; 2010 Jun; 16(5):316-23. PubMed ID: 20359934
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of dystonia in Japan].
Mezaki T; Hayashi A; Nakase H; Hasegawa K
Rinsho Shinkeigaku; 2005 Sep; 45(9):634-42. PubMed ID: 16248394
[TBL] [Abstract][Full Text] [Related]
9. [Problems of treating writer's cramp with botulinum toxin injections: results from 10 years of experience].
Marion MH; Afors K; Sheehy MP
Rev Neurol (Paris); 2003 Oct; 159(10 Pt 1):923-7. PubMed ID: 14615682
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
11. Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study.
Marchetti A; Magar R; Findley L; Larsen JP; Pirtosek Z; Růzicka E; Jech R; Sławek J; Ahmed F
Mov Disord; 2005 Aug; 20(8):937-44. PubMed ID: 15810022
[TBL] [Abstract][Full Text] [Related]
12. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
Hsiung GY; Das SK; Ranawaya R; Lafontaine AL; Suchowersky O
Mov Disord; 2002 Nov; 17(6):1288-93. PubMed ID: 12465070
[TBL] [Abstract][Full Text] [Related]
14. Clinical changes of cervical dystonia pattern in long-term botulinum toxin treated patients.
Maia FM; Kanashiro AK; Chien HF; Gonçalves LR; Barbosa ER
Parkinsonism Relat Disord; 2010 Jan; 16(1):8-11. PubMed ID: 19589716
[TBL] [Abstract][Full Text] [Related]
15. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
Factor SA; Molho ES; Evans S; Feustel PJ
Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin in the treatment of writer's cramp.
Behari M
J Assoc Physicians India; 1999 Jul; 47(7):694-8. PubMed ID: 10778589
[TBL] [Abstract][Full Text] [Related]
18. [Treating writer's cramp: 14 years' experience with botulinum toxin].
Somma-Mauvais H; Soulayrol S; Duvocelle A; Azulay JP; Gastaut JL
Rev Neurol (Paris); 2010; 166(6-7):630-8. PubMed ID: 20189211
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
[TBL] [Abstract][Full Text] [Related]
20. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]